Inhibition Of H3K27-Methylome As a Novel Therapeutic Strategy In Multiple Myeloma

被引：0
|
作者：
Gkotzamanidou, Maria
Shammas, Masood A.
Qi, Jun
Samur, Mehmet Kemal
Hideshima, Teru
Dimopoulos, Meletios A.
Anderson, Kenneth C.
Bradner, James E.
Munshi, Nikhil
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3162
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Histone Demethylase Inhibition As a Novel Therapeutic Strategy in Myeloma
    Pawlyn, Charlotte
    Hookway, Edward
    Cain, Peter
    Pliuskys, Laurynas
    Kaiser, Martin F.
    Bright, Michael
    Aronson, Lauren I.
    Murison, Alexander
    Lindow, Morten
    Obad, Susanna
    Oerum, Henrik
    Opperman, Udo
    Morgan, Gareth J.
    Davies, Faith E.
    BLOOD, 2014, 124 (21)
  • [2] Gck Inhibition Is a Novel Therapeutic Strategy for RAS Mutated Multiple Myeloma and Overcomes Resistance to IMiDs
    Li, Shirong
    Fu, Jing
    Yang, Jun
    Mapara, Markus Y.
    Marcireau, Christophe
    Lentzsch, Suzanne
    BLOOD, 2020, 136
  • [3] THERAPEUTIC STRATEGY IN MULTIPLE-MYELOMA
    DURIE, BGM
    SALMON, S
    BULLETIN DU CANCER, 1980, 67 (04) : 450 - 457
  • [4] Current Therapeutic Strategy for Multiple Myeloma
    Suzuki, Kenshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 116 - 124
  • [5] Targeting CD47 As a Novel Therapeutic Strategy in Multiple Myeloma
    Muz, Barbara
    Kusdono, Hubert D.
    King, Justin
    Kohnen, Daniel
    Fiala, Mark A.
    Vij, Ravi
    Capoccia, Ben
    Manning, Pamela T.
    Salama, Noha Nabil
    Azab, Abdel Kareem
    BLOOD, 2017, 130
  • [6] Targeted Inhibition of Myeloperoxidase (MPO): A New Therapeutic Strategy for the Treatment of Multiple Myeloma
    Williams, Connor
    Noll, Jacqueline
    Harnas, Dylan
    Parkinson, Hayley
    Hewett, Duncan
    Wyllie, Kaitlin
    Cox, Thomas
    Zannettino, Andrew
    Vandyke, Kate
    Panagopoulos, Vasilios
    BLOOD, 2023, 142
  • [7] Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
    Tai, Yu-Tzu
    Chang, Betty Y.
    Kong, Sun-Young
    Fulciniti, Mariateresa
    Yang, Guang
    Calle, Yolanda
    Hu, Yiguo
    Lin, Jianhong
    Zhao, Jian-Jun
    Cagnetta, Antonia
    Cea, Michele
    Sellitto, Michael A.
    Zhong, Mike Y.
    Wang, Qiuju
    Acharya, Chirag
    Carrasco, Daniel R.
    Buggy, Joseph J.
    Elias, Laurence
    Treon, Steven P.
    Matsui, William
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (09) : 1877 - 1887
  • [8] PDK1 inhibition is a novel therapeutic target in multiple myeloma
    S Fujiwara
    Y Kawano
    H Yuki
    Y Okuno
    K Nosaka
    H Mitsuya
    H Hata
    British Journal of Cancer, 2013, 108 : 170 - 178
  • [9] RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma
    Lee, Hans C.
    Wang, Hua
    Baladandayuthapani, Veerabhadran
    Lin, Heather
    He, Jin
    Jones, Richard J.
    Kuiatse, Isere
    Gu, Dongmin
    Wang, Zhiqiang
    Ma, Wencai
    Lim, John
    O'Brien, Sean
    Keats, Jonathan
    Yang, Jing
    Davis, Richard E.
    Orlowski, Robert Z.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (01) : 80 - 94
  • [10] PDK1 inhibition is a novel therapeutic target in multiple myeloma
    Fujiwara, S.
    Kawano, Y.
    Yuki, H.
    Okuno, Y.
    Nosaka, K.
    Mitsuya, H.
    Hata, H.
    BRITISH JOURNAL OF CANCER, 2013, 108 (01) : 170 - 178
12345